BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Intestine
,
Anticancer prodrugs
,
Lipopolysaccharide
,
rs3825942
,
GATA1
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NT 3 growth factor receptor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Myxoid spindle cell sarcoma with ETV6-NTRK3 fusion.
Identification and structural analysis of a selective tropomyosin receptor kinase C (TRKC) inhibitor…
Do catecholaminergic TrkC DRG neurons represent a class of cardiovascular enteroceptor?
TrkC Is Essential for Nephron Function and Trans-Activates Igf1R Signaling.
Therapeutic targeting of RBPJ, an upstream regulator of ETV6 gene, abrogates ETV6-NTRK3 fusion gene …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP and GDF-15, of Heart Fa…
Safety and Efficacy of the PAINLESS Nerve Growth Factor CHF6467 in Optic Pathway Glioma (OPG)
A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2
Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Subjects With Ho…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ